UCSF Update on Heart Failure Therapies 2025
Introduction
The UCSF Update on Heart Failure Therapies 2025 is an advanced cardiovascular education program from University of California San Francisco focused on contemporary management of heart failure, cardiogenic shock, pulmonary hypertension, cardiac amyloidosis, mechanical circulatory support, and advanced heart failure therapies.
Designed for clinicians managing complex cardiovascular disease, this course delivers evidence-based updates on guideline-directed medical therapy (GDMT), remote monitoring technologies, durable LVADs, heart transplantation, right heart failure, and multidisciplinary heart failure care.
The curriculum emphasizes practical integration of emerging therapies and advanced cardiovascular interventions into modern patient-centered heart failure management programs.
Course Overview
This educational program provides a comprehensive review of evolving therapies and innovations in advanced heart failure care.
Included Materials
- 3 educational videos
- 17 PDF presentations and learning materials
Educational Focus
- Guideline-directed heart failure therapy
- Cardiogenic shock management
- Mechanical circulatory support (MCS)
- Left ventricular assist devices (LVADs)
- Heart transplantation
- Pulmonary hypertension
- Cardiac amyloidosis
- Advanced multidisciplinary heart failure care
- Remote monitoring technologies
- Structural and valvular heart interventions
The course integrates advanced heart failure cardiology, critical care, transplant medicine, structural heart disease, and cardiovascular innovation into a focused educational platform.
Why This Course Is Important
Heart failure affects millions of patients worldwide and remains one of the leading causes of hospitalization and cardiovascular mortality, especially among older adults.
Modern heart failure care now includes major advances in:
- Guideline-directed medical therapy
- SGLT2 inhibitor integration
- Remote hemodynamic monitoring
- Acute mechanical circulatory support
- Durable LVAD technologies
- Heart transplantation
- Cardiac amyloidosis therapies
- Structural heart interventions
- Precision and multidisciplinary cardiovascular care
Management of advanced heart failure increasingly requires coordination between:
- Cardiologists
- Heart failure specialists
- Cardiothoracic surgeons
- Intensivists
- Electrophysiologists
- Pulmonary hypertension teams
- Community physicians
- Advanced practice providers
The UCSF course addresses these evolving challenges through practical, evidence-based cardiovascular education focused on improving outcomes in complex heart failure patients.
What Participants Will Learn
Participants completing this course will strengthen their expertise in modern heart failure therapies and advanced cardiovascular management.
Learning objectives include:
- Applying updated heart failure treatment guidelines
- Optimizing GDMT for chronic heart failure
- Understanding remote monitoring technologies
- Managing cardiogenic shock and acute decompensated HF
- Evaluating acute and durable mechanical circulatory support devices
- Understanding minimally invasive LVAD implantation strategies
- Applying modern heart transplantation approaches
- Managing pulmonary hypertension and right heart failure
- Evaluating and treating cardiac amyloidosis
- Integrating multidisciplinary care pathways for advanced cardiac patients
The curriculum combines heart failure medicine, cardiovascular critical care, transplant cardiology, pulmonary vascular disease, and structural heart management into a practical clinical learning experience.
Core Topics & Educational Areas
Guideline-Directed Medical Therapy (GDMT)
Optimization of HF Pharmacotherapy
Contemporary HF Guidelines
Novel Heart Failure Medications
Clinical Trial Updates
Remote Monitoring & Digital Heart Failure Care
Hemodynamic Monitoring
Remote Patient Management
Chronic HF Monitoring Technologies
Outpatient Heart Failure Management
Cardiogenic Shock
Acute HF Stabilization
Shock Team Models
Refractory Cardiogenic Shock
ICU-Based Heart Failure Care
Mechanical Circulatory Support (MCS)
Acute Mechanical Support Devices
Durable LVADs
Minimally Invasive LVAD Implantation
MCS Patient Selection
Shared Care Programs
Heart Transplantation
Organ Procurement & Preservation
Expanded Donor Criteria
Dual Organ Transplantation
Post-Transplant Care
Advanced Transplant Innovations
Cardiac Amyloidosis
ATTR & AL Amyloidosis
Diagnostic Strategies
Novel Amyloidosis Therapies
Imaging & Clinical Management
Pulmonary Hypertension & Right Heart Failure
PH in Advanced HF
RV Failure Management
Hemodynamic Assessment
Pulmonary Vascular Therapies
Structural & Valvular Heart Disease
Novel Valve Therapeutics
Structural Interventions in HF
Advanced Imaging & Assessment
Genetic & Advanced Cardiomyopathies
Genetic Cardiomyopathy Evaluation
Precision Cardiovascular Medicine
Advanced HF Phenotyping
Multidisciplinary Heart Failure Programs
Community–Academic Partnerships
Coordinated HF Care Models
Longitudinal Advanced Cardiac Care
Patient-Centered HF Management
Educational Experience & Learning Features
The UCSF Update on Heart Failure Therapies 2025 combines evidence-based cardiovascular science with practical advanced heart failure education.
Educational features include:
- Expert-led heart failure lectures
- Advanced therapy discussions
- Guideline-focused education
- Cardiogenic shock management strategies
- LVAD and transplant updates
- Pulmonary hypertension education
- Cardiac amyloidosis reviews
- Multidisciplinary HF care discussions
- Community cardiology integration models
- PDF-based advanced learning materials
The course integrates heart failure medicine, transplant cardiology, cardiovascular surgery, critical care, and multidisciplinary patient management into a comprehensive educational experience.
Who Should Attend
This educational program is intended for healthcare professionals involved in cardiovascular and heart failure care.
This course is especially valuable for:
- Cardiologists
- Heart failure specialists
- Internists
- Family medicine physicians
- Cardiovascular intensivists
- Transplant cardiologists
- Advanced practice providers
- Pharmacists
- Nurses involved in HF care
- Fellows and trainees in cardiovascular medicine
The curriculum is particularly relevant for clinicians seeking advanced updates in modern heart failure therapy and complex cardiovascular patient management.
Clinical Applications & Practice Benefits
The UCSF Update on Heart Failure Therapies 2025 provides clinically practical education focused on improving outcomes in patients with advanced cardiovascular disease.
Participants gain practical insight into:
- GDMT optimization strategies
- Acute cardiogenic shock management
- Mechanical circulatory support selection
- Durable LVAD management
- Heart transplant evaluation and care
- Pulmonary hypertension treatment
- Cardiac amyloidosis diagnosis and therapy
- Remote heart failure monitoring
- Multidisciplinary care coordination
- Advanced patient-centered cardiovascular management
The educational content strengthens both clinical decision-making and advanced heart failure management expertise.
Professional Summary
The UCSF Update on Heart Failure Therapies 2025 from University of California San Francisco delivers a comprehensive educational review of contemporary heart failure management, cardiogenic shock, pulmonary hypertension, mechanical circulatory support, heart transplantation, and advanced cardiovascular therapies.
Through expert-led presentations and evidence-based discussions, the course explores modern guideline-directed therapy, durable LVADs, remote monitoring, cardiac amyloidosis management, and multidisciplinary heart failure care strategies.
Its combination of advanced cardiovascular science, practical clinical application, transplant and MCS education, and patient-centered care models makes this program an essential resource for cardiologists, heart failure specialists, internists, and multidisciplinary cardiovascular clinicians.
+ Topics:
*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below
| Friday, September 12, 2025 | ||
| Time | Title | Speaker(s) |
| 7:00 – 8:00am | Registration/Continental Breakfast
Kenwood Foyer/Sonoma Valley Room Product Theater (Kenwood Room-Full Breakfast) – Kiniksa Pharmaceuticals Arcalyst: EVIDENCE-BASED TREATMENT OF RECURRENT PERICARDITIS |
John Ryan, MD |
| 8:05 – 8:30 | New Pillars of HFpEF Management | Pooja Prasad, MD |
| 8:35 – 9:00 | Improving Heart Failure Care by Treating its Comorbidities | Shweta Motiwala, MD |
| 9:05 – 9:30 | New Heart Failure Devices | Liviu Klein, MD |
| 9:35 – 10:15 | Heart Failure Clinic: the Cornerstone of Patient Care | Shweta Motiwala, MD Brandon Martinez, PharmD Robin Fischer, DNP Jamie Lee, RN Yuri Nam, NP |
| 10:15 – 10:30 | Break | |
| 10:35 – 11:00 | Multimodal Imaging in Cardiomyopathies | Michael Salerno, MD |
| 11:05 – 11:30 | Amyloid Cardiomyopathy: a Cinderella no More! | Mandar Aras, MD, PhD |
| 11:35 – 12:00 | What’s New in Pulmonary Hypertension? | Marc Simon, MD |
| 12:00 – 12:45 | Hosted Lunch | |
| 12:50 – 1:30 | Risk-Based Prevention of Heart Failure: A New Paradigm | Donald M. Lloyd-Jones, MD, ScM |
| 1:40 – 2:05 | Early Recognition of Advanced Heart Failure | Leila Beach, MD |
| 2:10 – 2:35 | The Rise of the Machines: LVADs for Long-Term Heart Failure Therapy | Mandar Aras, MD |
| 2:35 – 2:50 | Break | |
| 2:50 – 3:15 | Heart Transplantation in 2025: Back to the Future | Amy Fiedler, MD |
| 3:15 – 3:50 | Multidisciplinary Care: the Key to the Success of Transplant and LVAD Care | Jose Lazo, PharmD Julia Galeota, MSW Marvin Mailom, RN Simran Grewal, NP Ashley Jannesen, NP |
| 4:00 – 4:30 | GUARDIAN Angel: Organ Transport Updates | Amy Fiedler, MD Liviu Klein, MD |
| 5:30 – 7:30 pm | Garden Reception | |
| Saturday, September 13, 2025 | ||
| Time | Title | Speaker(s) |
| 7:00 – 8:05 am | Continental Breakfast
Sonoma Valley Room Product Theater (Kenwood Room-Full Breakfast) – Alnylam Pharmaceuticals Introduction to AMVUTTRA (Vutrisiran) for the treatment of ATTR-CM and hATTR-PN in Adults |
Mandar Aras, MD, PhD |
| 8:05 – 8:25 | A Primer for Non-Transplant Providers in Caring for Heart Transplant Patients | Jaqueline DesJardin, MD |
| 8:30 – 8:55 | Cardiogenic Shock after DanGer | Connor O’Brien, MD |
| 9:00 – 10:00 | What if a Heart Transplant or LVAD Patient Show up in my ER (case studies) | Connor O’Brien, MD Jaqueline DesJardin, MD Faculty Panel |
| 10:00 – 10:15 | Break | |
| 10:15 – 11:55 | Collaboration for Complex Cases: Bring your Challenging cases to Discuss | Amy Fiedler, MD Connor O’Brien Liviu Klein, MD Community cardiologists Faculty Panel |
